1-23694734-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000975.5(RPL11):​c.339C>T​(p.Ile113Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,614,106 control chromosomes in the GnomAD database, including 1,294 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 69 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1225 hom. )

Consequence

RPL11
NM_000975.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0180

Publications

8 publications found
Variant links:
Genes affected
RPL11 (HGNC:10301): (ribosomal protein L11) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L5P family of ribosomal proteins. It is located in the cytoplasm. The protein probably associates with the 5S rRNA. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Dec 2010]
RPL11 Gene-Disease associations (from GenCC):
  • Diamond-Blackfan anemia 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Diamond-Blackfan anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 1-23694734-C-T is Benign according to our data. Variant chr1-23694734-C-T is described in ClinVar as Benign. ClinVar VariationId is 296821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.018 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0249 (3793/152276) while in subpopulation NFE AF = 0.0393 (2671/68014). AF 95% confidence interval is 0.038. There are 69 homozygotes in GnomAd4. There are 1751 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3793 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000975.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPL11
NM_000975.5
MANE Select
c.339C>Tp.Ile113Ile
synonymous
Exon 4 of 6NP_000966.2
RPL11
NM_001199802.1
c.336C>Tp.Ile112Ile
synonymous
Exon 4 of 6NP_001186731.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPL11
ENST00000643754.2
MANE Select
c.339C>Tp.Ile113Ile
synonymous
Exon 4 of 6ENSP00000496250.1
RPL11
ENST00000374550.8
TSL:1
c.336C>Tp.Ile112Ile
synonymous
Exon 4 of 6ENSP00000363676.4
RPL11
ENST00000458455.2
TSL:1
c.306C>Tp.Ile102Ile
synonymous
Exon 3 of 5ENSP00000398888.2

Frequencies

GnomAD3 genomes
AF:
0.0249
AC:
3795
AN:
152158
Hom.:
69
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00777
Gnomad AMI
AF:
0.0549
Gnomad AMR
AF:
0.0174
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.00539
Gnomad FIN
AF:
0.0335
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.0234
GnomAD2 exomes
AF:
0.0246
AC:
6180
AN:
251458
AF XY:
0.0242
show subpopulations
Gnomad AFR exome
AF:
0.00615
Gnomad AMR exome
AF:
0.0125
Gnomad ASJ exome
AF:
0.0113
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0354
Gnomad NFE exome
AF:
0.0387
Gnomad OTH exome
AF:
0.0236
GnomAD4 exome
AF:
0.0368
AC:
53781
AN:
1461830
Hom.:
1225
Cov.:
31
AF XY:
0.0356
AC XY:
25895
AN XY:
727212
show subpopulations
African (AFR)
AF:
0.00565
AC:
189
AN:
33480
American (AMR)
AF:
0.0135
AC:
606
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0110
AC:
287
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39698
South Asian (SAS)
AF:
0.00796
AC:
687
AN:
86256
European-Finnish (FIN)
AF:
0.0330
AC:
1765
AN:
53420
Middle Eastern (MID)
AF:
0.0107
AC:
62
AN:
5768
European-Non Finnish (NFE)
AF:
0.0433
AC:
48192
AN:
1111956
Other (OTH)
AF:
0.0330
AC:
1990
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2922
5844
8765
11687
14609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1808
3616
5424
7232
9040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0249
AC:
3793
AN:
152276
Hom.:
69
Cov.:
32
AF XY:
0.0235
AC XY:
1751
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00775
AC:
322
AN:
41560
American (AMR)
AF:
0.0173
AC:
265
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5190
South Asian (SAS)
AF:
0.00539
AC:
26
AN:
4824
European-Finnish (FIN)
AF:
0.0335
AC:
356
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0393
AC:
2671
AN:
68014
Other (OTH)
AF:
0.0232
AC:
49
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
199
399
598
798
997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0329
Hom.:
186
Bravo
AF:
0.0226
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Diamond-Blackfan anemia 7 Benign:2
Aug 01, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Diamond-Blackfan anemia Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 25, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
12
DANN
Benign
0.56
PhyloP100
0.018
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8880; hg19: chr1-24021224; API